We evaluated the antitumor effects of silencing ZDHHC5 in vitro and in vivo, confirming that ZDHHC5 is a potential target for inhibiting pancreatic cancer cell proliferation (Figs. 1–3). Here, ZDHHC5 is linked to familial pancreatic carcinoma.